Summit Partners, a growth equity investor, has appointed two senior healthcare investment professionals: Darren Black, managing director in Summit’s Boston office, and Thomas Tarnowski, principal in Summit’s London office.
Since 1984, Summit has invested in more than 70 companies across the healthcare and life sciences industry.
“We’re delighted to welcome Darren and Thomas to our experienced team,” says Marty Mannion, a managing director in Summit’s Boston office. “Their deep knowledge and sector expertise will help Summit build on its nearly 30-year history of investing in the healthcare sector. We’re very much looking forward to working with them.”
Black brings more than 20 years of healthcare investment and entrepreneurial experience. Prior to joining Summit, Black was a managing partner with SV Life Sciences where he focused on investing in healthcare services, healthcare information technology and pharmaceutical services. During his 10 years with SV Life Sciences, he sat on numerous boards including Vitalize Consulting Solutions, Celerion and Spectrum Professional Services. Before SV Life Sciences, Black was co-founder and president of two specialty contract research service businesses: ClinCare and PharmaStar. Prior to that, he was a healthcare consultant for Accenture.
Tarnowski is a Danish national with more than 12 years of investing and healthcare experience in the US, UK and Central and Northern Europe. Tarnowski will lead Summit’s healthcare and life sciences team in Europe. Prior to joining Summit, he led Triton’s Nordic healthcare team focusing mainly on healthcare services and medical technology investments. During his seven years with Triton, Tarnowski served on several boards including one of the largest healthcare services companies in the Nordic region. Before Triton, he worked for Credit Suisse First Boston in the financial sponsors group covering North America.